Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2014

Open Access 01-12-2014 | Original investigation

Normal weight diabetic patients versus obese diabetics: relation of overall and abdominal adiposity to vascular health

Authors: Alla Lukich, Dov Gavish, Marina Shargorodsky

Published in: Cardiovascular Diabetology | Issue 1/2014

Login to get access

Abstract

Objective

The present study investigated the impact of overall obesity defined by BMI and abdominal obesity defined by WC on vascular atherosclerotic changes in obese and normal weight diabetic subjects.

Design and methods

285 subjects were divided according to presence diabetes mellitus (DM) and obesity: Group 1 included 144 nonobese subjects without DM; Group 2 consisted of 141 type 2 diabetic patients. Then diabetic patients were divided into two groups according to presence of overall obesity, defined by BMI and furthermore, abdominal obesity, defined by waist circumference (WC). Pulse wave velocity (PWV) and augmentation index (AI) were performed using SphygmoCor (version 7.1, AtCor Medical, Sydney, Australia).

Results

Between Group Comparisons by BMI: Diabetic subjects with and without overall obesity did not differ from one another in terms of AI and PWV.
Between Group Comparisons by WC: AI as well as PWV increased consistently from Group 1 to Group 3, AI and PWV were significantly higher in abdominally obese diabetic subjects than in the diabetics without abdominal obesity (p = 0.008 and p = 0.013, respectively). Significant by-group differences in PWV and AI persisted after adjustment for age, sex, blood pressure, fasting glucose and BMI.

Conclusions

Abdominal obesity defined by WC was associated with significantly higher AI and PWV in in both diabetic men and women; whereas overall obesity defined by BMI did not predict adverse vascular changes in this study population. Abdominal obesity was associated with an adverse effect on blood vessels, independently of age, sex, blood pressure, fasting glucose and BMI.
Appendix
Available only for authorised users
Literature
1.
go back to reference Zieman SJ, Melenovsky V, Kass DA:Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol. 2005, 25: 932-943. 10.1161/01.ATV.0000160548.78317.29.CrossRefPubMed Zieman SJ, Melenovsky V, Kass DA:Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol. 2005, 25: 932-943. 10.1161/01.ATV.0000160548.78317.29.CrossRefPubMed
2.
go back to reference Giannattasio C, Mancia G:Arterial distensibility in humans. Modulating mechanisms, alterations in diseases and effects of treatment. J Hypertens. 2002, 20: 1889-1899. 10.1097/00004872-200210000-00001.CrossRefPubMed Giannattasio C, Mancia G:Arterial distensibility in humans. Modulating mechanisms, alterations in diseases and effects of treatment. J Hypertens. 2002, 20: 1889-1899. 10.1097/00004872-200210000-00001.CrossRefPubMed
3.
go back to reference Montagnani M, Quon MJ:Insulin action in vascular endothelium: potential mechanisms linking insulin resistance with hypertension. Diabetes Obes Metab. 2000, 2: 285-292. 10.1046/j.1463-1326.2000.00092.x.CrossRefPubMed Montagnani M, Quon MJ:Insulin action in vascular endothelium: potential mechanisms linking insulin resistance with hypertension. Diabetes Obes Metab. 2000, 2: 285-292. 10.1046/j.1463-1326.2000.00092.x.CrossRefPubMed
4.
go back to reference Greenfield GR, Samaras K, Chisholm DJ, Campbell LV:Effect of postprandial insulinemia and insulin resistance on measurement of arterial stiffness (augmentation index). Int J Cardiol. 2007, 114: 50-56. 10.1016/j.ijcard.2005.12.007.CrossRefPubMed Greenfield GR, Samaras K, Chisholm DJ, Campbell LV:Effect of postprandial insulinemia and insulin resistance on measurement of arterial stiffness (augmentation index). Int J Cardiol. 2007, 114: 50-56. 10.1016/j.ijcard.2005.12.007.CrossRefPubMed
5.
go back to reference Suraamornkul S, Kwancharoen R, Ovartlarnporn M, Rawdaree P, Bajaj M:Insulin clamp-derived measurements of insulin sensitivity and insulin secretion in lean and obese asian type 2 diabetic patients. Metab Syndr Relat Disord. 2010, 8 (2): 113-118. 10.1089/met.2009.0030.CrossRefPubMed Suraamornkul S, Kwancharoen R, Ovartlarnporn M, Rawdaree P, Bajaj M:Insulin clamp-derived measurements of insulin sensitivity and insulin secretion in lean and obese asian type 2 diabetic patients. Metab Syndr Relat Disord. 2010, 8 (2): 113-118. 10.1089/met.2009.0030.CrossRefPubMed
6.
go back to reference Meneilly GS, Elliott T:Metabolic alterations in middle-aged and elderly obese patients with type 2 diabetes. Diabetes Care. 1999, 22: 112-118. 10.2337/diacare.22.1.112.CrossRefPubMed Meneilly GS, Elliott T:Metabolic alterations in middle-aged and elderly obese patients with type 2 diabetes. Diabetes Care. 1999, 22: 112-118. 10.2337/diacare.22.1.112.CrossRefPubMed
7.
go back to reference Liao J, Farmer J: Arterial stiffness as a risk factor for coronary artery disease.Curr Atheroscler Rep 2014, 16(2):387.,CrossRefPubMed Liao J, Farmer J: Arterial stiffness as a risk factor for coronary artery disease.Curr Atheroscler Rep 2014, 16(2):387.,CrossRefPubMed
8.
go back to reference Van Popele NM, Grobbee DE, Bots ML, Asmar R, Topouchian J, Reneman RS, Hoeks AP, van der Kuip DA, Hofman A, Witteman JC:Association between arterial stiffness and atherosclerosis: the Rotterdam study. Stroke. 2001, 32: 454-460. 10.1161/01.STR.32.2.454.CrossRefPubMed Van Popele NM, Grobbee DE, Bots ML, Asmar R, Topouchian J, Reneman RS, Hoeks AP, van der Kuip DA, Hofman A, Witteman JC:Association between arterial stiffness and atherosclerosis: the Rotterdam study. Stroke. 2001, 32: 454-460. 10.1161/01.STR.32.2.454.CrossRefPubMed
9.
go back to reference Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG:Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance. An integrated index of vascular function?. Circulation. 2002, 106: 2085-2090. 10.1161/01.CIR.0000033824.02722.F7.CrossRefPubMed Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG:Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance. An integrated index of vascular function?. Circulation. 2002, 106: 2085-2090. 10.1161/01.CIR.0000033824.02722.F7.CrossRefPubMed
10.
go back to reference O’Rourke M, Staessen JA:Clinical application of arterial stiffness definitions and reference values. Am J Hypertens. 2002, 15: 426-444. 10.1016/S0895-7061(01)02319-6.CrossRefPubMed O’Rourke M, Staessen JA:Clinical application of arterial stiffness definitions and reference values. Am J Hypertens. 2002, 15: 426-444. 10.1016/S0895-7061(01)02319-6.CrossRefPubMed
11.
go back to reference Martínez-González MA, García-Arellano A, Toledo E, Bes-Rastrollo M, BullóM, Corella D, Fito M, Ros E, Lamuela-Raventós RM, Rekondo J, Gómez-Gracia E, Fiol M, Santos-Lozano JM, Serra-Majem L, Martínez JA, Eguaras S, Sáez-Tormo G, Pintó X, Estruch R: Obesity indexes and total mortality among elderly subjects at high cardiovascular risk: the PREDIMED study.PLoS One 2014, 29:9(7)., Martínez-González MA, García-Arellano A, Toledo E, Bes-Rastrollo M, BullóM, Corella D, Fito M, Ros E, Lamuela-Raventós RM, Rekondo J, Gómez-Gracia E, Fiol M, Santos-Lozano JM, Serra-Majem L, Martínez JA, Eguaras S, Sáez-Tormo G, Pintó X, Estruch R: Obesity indexes and total mortality among elderly subjects at high cardiovascular risk: the PREDIMED study.PLoS One 2014, 29:9(7).,
12.
go back to reference Recio-Rodriguez JI, Gomez-Marcos MA, Patino-Alonso MC, Agudo-Conde C, Rodriguez-Sanchez E, Garcia-Ortiz L, Vasorisk group: Abdominal obesity vs general obesity for identifying arterial stiffness, subclinical atherosclerosis and wave reflection in healthy, diabetics and hypertensive.BMC Cardiovasc Disord 2012, 12:3., Recio-Rodriguez JI, Gomez-Marcos MA, Patino-Alonso MC, Agudo-Conde C, Rodriguez-Sanchez E, Garcia-Ortiz L, Vasorisk group: Abdominal obesity vs general obesity for identifying arterial stiffness, subclinical atherosclerosis and wave reflection in healthy, diabetics and hypertensive.BMC Cardiovasc Disord 2012, 12:3.,
13.
go back to reference Cox BD, Whichelow MJ, Prevost AT:The development of cardiovascular disease in relation to anthropometric indices and hypertension in British adults. Int J Obes Relat Metab Disord. 1998, 22: 966-973. 10.1038/sj.ijo.0800705.CrossRefPubMed Cox BD, Whichelow MJ, Prevost AT:The development of cardiovascular disease in relation to anthropometric indices and hypertension in British adults. Int J Obes Relat Metab Disord. 1998, 22: 966-973. 10.1038/sj.ijo.0800705.CrossRefPubMed
14.
go back to reference Taylor AE, Ebrahim S, Ben-Shlomo Y, Martin RM, Whincup PH, Yarnell JW, Wannamethee SG, Lawlor DA:Comparison of the associations of body mass index and measures of central adiposity and fat mass with coronary heart disease, diabetes, and all-cause mortality: a study using data from 4 UK cohorts. Am J Clin Nutr. 2010, 91: 547-556. 10.3945/ajcn.2009.28757.CrossRefPubMed Taylor AE, Ebrahim S, Ben-Shlomo Y, Martin RM, Whincup PH, Yarnell JW, Wannamethee SG, Lawlor DA:Comparison of the associations of body mass index and measures of central adiposity and fat mass with coronary heart disease, diabetes, and all-cause mortality: a study using data from 4 UK cohorts. Am J Clin Nutr. 2010, 91: 547-556. 10.3945/ajcn.2009.28757.CrossRefPubMed
15.
go back to reference Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, Vasan RS, Murabito JM, Meigs JB, Cupples LA, D’Agostino RBS, O’Donnell CJ:Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham heart study. Circulation. 2007, 116 (1): 39-48. 10.1161/CIRCULATIONAHA.106.675355.CrossRefPubMed Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, Vasan RS, Murabito JM, Meigs JB, Cupples LA, D’Agostino RBS, O’Donnell CJ:Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham heart study. Circulation. 2007, 116 (1): 39-48. 10.1161/CIRCULATIONAHA.106.675355.CrossRefPubMed
16.
go back to reference Liu J, Fox CS, Hickson DA, May WD, Hairston KG, Carr JJ, Taylor HA:Impact of abdominal visceral and subcutaneous adipose tissue on cardiometabolic risk factors: the Jackson heart study. J Clin Endocrinol Metab. 2010, 95 (12): 5419-5426. 10.1210/jc.2010-1378.PubMedCentralCrossRefPubMed Liu J, Fox CS, Hickson DA, May WD, Hairston KG, Carr JJ, Taylor HA:Impact of abdominal visceral and subcutaneous adipose tissue on cardiometabolic risk factors: the Jackson heart study. J Clin Endocrinol Metab. 2010, 95 (12): 5419-5426. 10.1210/jc.2010-1378.PubMedCentralCrossRefPubMed
17.
go back to reference Pou KM, Massaro JM, Hoffmann U, Vasan RS, Maurovich-Horvat P, Larson MG, Keaney JF, Meigs JB, Lipinska I, Kathiresan S, Murabito JM, O’Donnell CJ, Benjamin EJ, Fox CS:Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham heart study. Circulation. 2007, 116 (11): 1234-1241. 10.1161/CIRCULATIONAHA.107.710509.CrossRefPubMed Pou KM, Massaro JM, Hoffmann U, Vasan RS, Maurovich-Horvat P, Larson MG, Keaney JF, Meigs JB, Lipinska I, Kathiresan S, Murabito JM, O’Donnell CJ, Benjamin EJ, Fox CS:Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham heart study. Circulation. 2007, 116 (11): 1234-1241. 10.1161/CIRCULATIONAHA.107.710509.CrossRefPubMed
18.
go back to reference Tan KCB, Xu A, Chow WS, Lam MCW, Ai VHG, Tam SCF, Lam KSL:Hypoadiponectinemia is associated with impaired endothelium-dependent vasodilation. J Clin Endocrinol Metab. 2004, 89: 765-769. 10.1210/jc.2003-031012.CrossRefPubMed Tan KCB, Xu A, Chow WS, Lam MCW, Ai VHG, Tam SCF, Lam KSL:Hypoadiponectinemia is associated with impaired endothelium-dependent vasodilation. J Clin Endocrinol Metab. 2004, 89: 765-769. 10.1210/jc.2003-031012.CrossRefPubMed
19.
go back to reference Störk S, Bots ML, Angerer P, Schacky C, Grobbee DE, Angermann CE, Seufert J:Low levels of adiponectin predict worsening of arterial morphology and function. Atherosclerosis. 2007, 194: e147-e153. 10.1016/j.atherosclerosis.2006.11.044.CrossRefPubMed Störk S, Bots ML, Angerer P, Schacky C, Grobbee DE, Angermann CE, Seufert J:Low levels of adiponectin predict worsening of arterial morphology and function. Atherosclerosis. 2007, 194: e147-e153. 10.1016/j.atherosclerosis.2006.11.044.CrossRefPubMed
20.
go back to reference Yang R, Barouch LA:Leptin signaling and obesity: cardiovascular consequences. Circ Res. 2007, 101: 545-559. 10.1161/CIRCRESAHA.107.156596.CrossRefPubMed Yang R, Barouch LA:Leptin signaling and obesity: cardiovascular consequences. Circ Res. 2007, 101: 545-559. 10.1161/CIRCRESAHA.107.156596.CrossRefPubMed
21.
go back to reference Protopsaltis I, Foussas S, Angelidi A, Gritzapis A, Sergentanis TN, Matsagos S, Tzirogiannis K, Panoutsopoulos GI, Dimitriadis G, Raptis S, Melidonis A: Impact of ADMA, endothelial progenitor cells and traditional cardiovascular risk factors on pulse wave velocity among prediabetic individuals.Cardiovasc Diabetol 2012, 11:141., Protopsaltis I, Foussas S, Angelidi A, Gritzapis A, Sergentanis TN, Matsagos S, Tzirogiannis K, Panoutsopoulos GI, Dimitriadis G, Raptis S, Melidonis A: Impact of ADMA, endothelial progenitor cells and traditional cardiovascular risk factors on pulse wave velocity among prediabetic individuals.Cardiovasc Diabetol 2012, 11:141.,
22.
go back to reference Sutton-Tyrrell K, Newman A, Simonsick EM, Havlik R, Pahor M, Lakatta E, Spurgeon H, Vaitkevicius P:Aortic stiffness is associated with visceral adiposity in older adults enrolled in the study of health, aging, and body composition. Hypertension. 2001, 38: 429-433. 10.1161/01.HYP.38.3.429.CrossRefPubMed Sutton-Tyrrell K, Newman A, Simonsick EM, Havlik R, Pahor M, Lakatta E, Spurgeon H, Vaitkevicius P:Aortic stiffness is associated with visceral adiposity in older adults enrolled in the study of health, aging, and body composition. Hypertension. 2001, 38: 429-433. 10.1161/01.HYP.38.3.429.CrossRefPubMed
23.
go back to reference Dahlén EM, Tengblad A, Länne T, Clinchy B, Ernerudh J, Nystrom FH, Östgren CJ:Abdominal obesity and low-grade systemic inflammation as markers of subclinical organ damage in type 2 diabetes. Diabetes Metab. 2014, 40 (1): 76-81. 10.1016/j.diabet.2013.10.006.CrossRefPubMed Dahlén EM, Tengblad A, Länne T, Clinchy B, Ernerudh J, Nystrom FH, Östgren CJ:Abdominal obesity and low-grade systemic inflammation as markers of subclinical organ damage in type 2 diabetes. Diabetes Metab. 2014, 40 (1): 76-81. 10.1016/j.diabet.2013.10.006.CrossRefPubMed
24.
go back to reference Dahlén EM, Bjarnegård N, Länne T, Nystrom FH, Ostgren CJ: Sagittal abdominal diameter is a more independent measure compared with waist circumference to predict arterial stiffness in subjects with type 2 diabetes-a prospective observational cohort study.Cardiovasc Diabetol 2013, 12:55., Dahlén EM, Bjarnegård N, Länne T, Nystrom FH, Ostgren CJ: Sagittal abdominal diameter is a more independent measure compared with waist circumference to predict arterial stiffness in subjects with type 2 diabetes-a prospective observational cohort study.Cardiovasc Diabetol 2013, 12:55.,
25.
go back to reference Liang J, Wang Y, Li H, Liu X, Qiu Q, Qi L: Neck circumference and early stage atherosclerosis: the cardiometabolic risk in Chinese (CRC) study.Cardiovasc Diabetol 2014, 13(1):107.,PubMedCentralCrossRefPubMed Liang J, Wang Y, Li H, Liu X, Qiu Q, Qi L: Neck circumference and early stage atherosclerosis: the cardiometabolic risk in Chinese (CRC) study.Cardiovasc Diabetol 2014, 13(1):107.,PubMedCentralCrossRefPubMed
26.
go back to reference Nickenig G, Roling J, Strehlow K, Schnabel P, Bohm M:Insulin induces upregulation of vascular AT1 receptor gene expression by posttranscriptional mechanisms. Circulation. 1998, 98: 2453-2460. 10.1161/01.CIR.98.22.2453.CrossRefPubMed Nickenig G, Roling J, Strehlow K, Schnabel P, Bohm M:Insulin induces upregulation of vascular AT1 receptor gene expression by posttranscriptional mechanisms. Circulation. 1998, 98: 2453-2460. 10.1161/01.CIR.98.22.2453.CrossRefPubMed
27.
go back to reference Brownlee M, Cerami A, Vlassara H:Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med. 1988, 318: 1315-1321. 10.1056/NEJM198805193182007.CrossRefPubMed Brownlee M, Cerami A, Vlassara H:Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med. 1988, 318: 1315-1321. 10.1056/NEJM198805193182007.CrossRefPubMed
28.
go back to reference Rizzoni D, Porteri E, Guelfi D, Muiesan ML, Valentini U, Cimino A, Girelli A, Rodella L, Bianchi R, Sleiman I, Rossei EA:Structural alterations in subcutaneous small arteries of normotensive and hypertensive patients with non-insulin-dependent diabetes mellitus. Circulation. 2001, 103: 1238-1244. 10.1161/01.CIR.103.9.1238.CrossRefPubMed Rizzoni D, Porteri E, Guelfi D, Muiesan ML, Valentini U, Cimino A, Girelli A, Rodella L, Bianchi R, Sleiman I, Rossei EA:Structural alterations in subcutaneous small arteries of normotensive and hypertensive patients with non-insulin-dependent diabetes mellitus. Circulation. 2001, 103: 1238-1244. 10.1161/01.CIR.103.9.1238.CrossRefPubMed
29.
go back to reference Hughes TM, Althouse AD, Niemczyk NA, Hawkins MS, Kuipers AL, Sutton-Tyrrell K: Effects of weight loss and insulin reduction on arterial stiffness in the SAVE trial.Cardiovasc Diabetol 2012, 11:114.,PubMedCentralCrossRefPubMed Hughes TM, Althouse AD, Niemczyk NA, Hawkins MS, Kuipers AL, Sutton-Tyrrell K: Effects of weight loss and insulin reduction on arterial stiffness in the SAVE trial.Cardiovasc Diabetol 2012, 11:114.,PubMedCentralCrossRefPubMed
30.
go back to reference Ikeda U, Takahashi M, Shimada K:C-reactive protein directly inhibits nitric oxid production by cytokine-stimulated vascular smooth muscle cell. J Cardiovasc Pharmacol. 2003, 42: 607-611. 10.1097/00005344-200311000-00005.CrossRefPubMed Ikeda U, Takahashi M, Shimada K:C-reactive protein directly inhibits nitric oxid production by cytokine-stimulated vascular smooth muscle cell. J Cardiovasc Pharmacol. 2003, 42: 607-611. 10.1097/00005344-200311000-00005.CrossRefPubMed
31.
go back to reference Verma S, Wang CH, Li SH, Dumont AS, Fedak PW, Badiwala MV, Dhillon B, Weisel RD, Li RK, Mickle DA, Stewart DJ:Sself-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation. 2002, 106: 913-919. 10.1161/01.CIR.0000029802.88087.5E.CrossRefPubMed Verma S, Wang CH, Li SH, Dumont AS, Fedak PW, Badiwala MV, Dhillon B, Weisel RD, Li RK, Mickle DA, Stewart DJ:Sself-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation. 2002, 106: 913-919. 10.1161/01.CIR.0000029802.88087.5E.CrossRefPubMed
32.
go back to reference Nordstrand N, Gjevestad E, Dinh KN, HofsøD, Røislien J, Saltvedt E, Os I, Hjelmesæth J: The relationship between various measures of obesity and arterial stiffness in morbidly obese patients.BMC Cardiovasc Disord 2011, 11:7.,PubMedCentralCrossRefPubMed Nordstrand N, Gjevestad E, Dinh KN, HofsøD, Røislien J, Saltvedt E, Os I, Hjelmesæth J: The relationship between various measures of obesity and arterial stiffness in morbidly obese patients.BMC Cardiovasc Disord 2011, 11:7.,PubMedCentralCrossRefPubMed
Metadata
Title
Normal weight diabetic patients versus obese diabetics: relation of overall and abdominal adiposity to vascular health
Authors
Alla Lukich
Dov Gavish
Marina Shargorodsky
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2014
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/s12933-014-0141-8

Other articles of this Issue 1/2014

Cardiovascular Diabetology 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine